We suggest that flaccidoxide-13-acetate may contribute to the inhibition of FAK and the subsequent suppression of PI3K/Akt/mTOR signaling, interrupting the EMT and the invasion and migration of HCC cells. This evidence concerns the gene AKT1 and hepatocellular carcinoma.